Novartis Investigative Site

Tarragona 43005

0 studies enrolling now · 2 studies all time

What they study most

Chronic Myelogenous Leukemia, Primary Prevention of Atherosclerotic Cardiovascular Disease

Studies at this site

• A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. — Running, not enrolling
• Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients — Completed